帕金森病和阿尔茨海默病会损害时间精度.
Research square
|February 6, 2026
概括
时间精度,但不是准确性,在帕金森氏症和阿尔茨海默氏症中始终受到损害. 这一发现强调了间隔时间作为神经退行性疾病的关键认知测试.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 神经学 神经学
背景情况:
- 像帕金森氏症和阿尔茨海默氏症这样的神经退行性疾病与时间处理缺陷有关.
- 间隔计时范例评估估计或产生时间间隔的能力,涉及工作记忆和注意力.
- 计时表现的关键指标包括时间准确性 (平均估计) 和时间精度 (估计的变化).
研究的目的:
- 在帕金森病和阿尔茨海默病患者中进行对时间准确度和精度进行元分析.
- 确定在这些神经退行性疾病的研究中是否一致观察到时间处理缺陷.
主要方法:
- 对14项涉及帕金森病患者的研究进行了元分析.
- 对10项涉及阿尔茨海默病患者的研究进行了元分析.
- 检查时间准确性和时间精确性作为主要结果措施.
主要成果:
- 在帕金森病和阿尔茨海默病的研究中,时间精度可靠地受到损害.
- 在这两种疾病中,时间精度并没有持续受到损害.
- 尽管采用了多种不同的方法,但时间精度受损却成为一个一致的发现.
结论:
- 时间精度是帕金森病和阿尔茨海默病认知功能障碍的强有力的指标.
- 间隔时间作为研究神经退行性疾病的认知缺陷的可靠测试.
- 这些发现可能扩展到其他神经和精神疾病与认知障碍.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
相关概念视频
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
